COLGATE PALMOLIVE CO
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $20.4B | $20.1B | $19.5B | $18.0B | $17.4B |
| Gross profit | $12.3B | $12.2B | $11.3B | $10.2B | $10.4B |
| Operating income | $3.3B | $4.3B | $4.0B | $2.9B | $3.3B |
| Cost of revenue | $8.1B | $7.9B | $8.1B | $7.7B | $7.0B |
| Cash from operations | $4.2B | $4.1B | $3.7B | $2.6B | $3.3B |
| Capital expenditure | $564.0M | $561.0M | $705.0M | $696.0M | $567.0M |
| Free cash flow | $3.6B | $3.5B | $3.0B | $1.9B | $2.8B |
| Share repurchases | $1.2B | $1.7B | $1.1B | $1.3B | $1.3B |
| Impairments | $582.0M | — | $0 | $332.0M | $367.0M |
| Total assets | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B |
| Total liabilities | $16.0B | $15.5B | $15.4B | $14.9B | $14.1B |
Shares outstanding 800.2M · Free float 99.6%
Annual filing data through FY ended December 31, 2025; float as of July 8, 2026.
Recent filings
- May 13, 2026 8-K
- May 1, 2026 10-Q
- May 1, 2026 8-K
- April 9, 2026 8-K
- March 17, 2026 8-K
- March 12, 2026 8-K
- February 23, 2026 10-K
- January 30, 2026 8-K